| JPM EMERGING MARKETS EQUITY I2 (ACC) EUR | RVI EMERGENTES | 63,49% | 79,34% | 33,47% | · |
| SCHRODER ISF CHINA A E ACC USD | RVI CHINA | 63,49% | 49,66% | 8,23% | · |
| SCHRODER ISF GLOBAL EMERGING MARKET OPPORTUNITIES C ACC EUR | RVI EMERGENTES | 63,49% | 82,48% | 53,86% | 210,40% |
| VANGUARD U.S. OPPORTUNITIES INVESTOR GBP DIS | RVI USA | 63,45% | 93,91% | 100,98% | 361,56% |
| UBS (LUX) KEY SELECTION SICAV - ASIAN EQUITIES (USD) Q-ACC | RVI ASIA EX-JAPÓN | 63,44% | 94,55% | 47,35% | 222,62% |
| JPM EMERGING MARKETS EQUITY C2 (ACC) EUR | RVI EMERGENTES | 63,43% | 79,12% | 33,19% | · |
| SCHRODER ISF GLOBAL EMERGING MARKET OPPORTUNITIES C ACC USD | RVI EMERGENTES | 63,42% | 81,76% | 53,77% | 210,19% |
| ABRDN SICAV I-EMERGING MARKETS EQUITY FUND A ACC EUR | RVI EMERGENTES | 63,41% | 73,52% | 28,91% | 98,43% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I-H CAP EUR | RVI BIOTECNOLOGÍA | 63,38% | 67,36% | 47,49% | 163,19% |
| SCHRODER ISF GLOBAL EMERGING MARKET OPPORTUNITIES C ACC GBP | RVI EMERGENTES | 63,36% | 82,16% | · | · |
